Arcus Biosciences

General Information


We are a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. Specifically, we target well-characterized biological pathways with significant scientific data supporting their importance in regulating the immune response against cancer and for which either there are no molecules in development or those that exist have suboptimal profiles. To exploit these pathways, we have built a robust and highly efficient discovery capability to create and optimize highly differentiated small-molecule immuno-oncology product candidates.


Employees: 83
Founded: 2015
Contact Information
Address 3928 Point Eden Way, Hayward, CA 94545, US
Phone Number (510) 694-6200.
Web Address
View Prospectus: Arcus Biosciences
Financial Information
Market Cap $583.1mil
Revenues $1.4 mil (last 12 months)
Net Income $-53.1 mil (last 12 months)
IPO Profile
Symbol RCUS
Exchange NYSE
Shares (millions): 8.0
Price range $15.00 - $15.00
Est. $ Volume $120.0 mil
Manager / Joint Managers Citigroup/ Goldman Sachs/ Leerink Partners
CO-Managers -
Expected To Trade: 3/15/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change